Electromed Inc Revenue Growth Rates (ELMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Electromed Inc   (NYSEAMER: ELMD)
 

ELMD's Revenue Growth by Quarter and Year

Electromed Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELMD Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 19.42
3rd Quarter March 17.64
2nd Quarter December 18.82
1st Quarter September 16.20
FY 72.08

ELMDs Annual Revenue
Electromed Inc 's Revenue in the fiscal year 2026 $ 73.78 millions
Electromed Inc 's Revenue in the fiscal year 2025 $ 63.97 millions
Electromed Inc 's Revenue in the fiscal year 2024 $ 54.72 millions
Electromed Inc 's Revenue in the fiscal year 2023 $ 48.07 millions
Electromed Inc 's Revenue in the fiscal year 2022 $ 41.66 millions




ELMD Revenue fourth quarter 2025 Y/Y Growth Comment
Electromed Inc reported Revenue growth of 8.96% year on year in the fourth quarter 2025, to $ 19.42 millions, this is lower than Electromed Inc 's recent average Revenue increase of 11.03%.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 97 other companies have achieved higher Revenue growth. While Electromed Inc ' s Revenue increase of 8.96% ranks overall at the positon no. 1833 in the fourth quarter 2025.


ELMD Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June 8.96 % 20.16 % 8.96 % 20.76 %
3rd Quarter March 15.82 % 9.81 % 14.91 % 19.03 %
2nd Quarter December 15.74 % 18.77 % 16.71 % 14.44 %
1st Quarter September 10.43 % 19.07 % 15.57 % 6.6 %
FY   12.66 % 16.94 % 13.81 % -

Financial Statements
Electromed Inc 's fourth quarter 2025 Revenue $ 19.42 millions ELMD's Income Statement
Electromed Inc 's fourth quarter 2024 Revenue $ 17.82 millions Quarterly ELMD's Income Statement


ELMD Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June 10.07 % 17.01 % 6.92 % 12.76 %
3rd Quarter March -6.27 % -6.33 % 1.31 % 2.9 %
2nd Quarter December 16.17 % 10.84 % 11.12 % 10.04 %
1st Quarter September -9.09 % -1.08 % -9.48 % -5.41 %
FY (Year on Year)   12.66 % 16.94 % 13.81 % -


Back to ELMD Growth rate Comparisons >> Back to ELMD Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #98
Healthcare Sector #285
Overall #1833

Revenue Y/Y Growth Statistics
High Average Low
39.56 % 11.03 % -33.01 %
(Dec 31 2014)   (Sep 30 2013)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #98
Healthcare Sector #285
Overall #1833
Revenue Y/Y Growth Statistics
High Average Low
39.56 % 11.03 % -33.01 %
(Dec 31 2014)   (Sep 30 2013)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Electromed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
54.92 % 3.3 % -33.21 %
(Sep 30 2011)  


ELMD's IV. Quarter Q/Q Revenue Comment
Electromed Inc achieved in the IV. Quarter 2025 above company average sequential Revenue rise of 10.07%, to $ 19.42 millions, from $17.64 millions in the third quarter.

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Electromed Inc 's Revenue growth quarter on quarter, overall rank is 818.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #124
Overall #818
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #124
Overall #818
Revenue Q/Q Growth Statistics
High Average Low
54.92 % 3.3 % -33.21 %
(Sep 30 2011)  


ELMD's IV. Quarter Q/Q Revenue Comment
Electromed Inc achieved in the IV. Quarter 2025 above company average sequential Revenue rise of 10.07%, to $ 19.42 millions, from $17.64 millions in the third quarter.

Within Medical Equipment & Supplies industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Electromed Inc 's Revenue growth quarter on quarter, overall rank is 818.


Electromed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 72.08 $ 70.48 $ 68.06 $ 65.50 $ 63.97
Y / Y Revenue Growth (TTM) 12.67 % 15.57 % 14.15 % 14.79 % 16.91 %
Year on Year Revenue Growth Overall Ranking # 1012 # 954 # 105 # 658 # 803
Seqeuential Revenue Change (TTM) 2.27 % 3.55 % 3.91 % 2.39 % 4.9 %
Seq. Revenue Growth (TTM) Overall Ranking # 2085 # 2206 # 273 # 1376 # 1763


Cumulative Revenue growth Comment
Assuming the Electromed Inc 's fiscal year would have ended in Jun 30 2026, Electromed Inc would have reprted above average annual Revenue increase of 12.67% year on year, of $ 72 millions.
This marks a slow-down of the companys growth trends and from the 15.57% rise in Mar 31 2026.

In the Healthcare sector 193 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 954 to 1012.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 194
Overall # 1012

Revenue TTM Y/Y Growth Statistics
High Average Low
28.9 %
 10.31 %
-22.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2085
Cumulative Revenue growth Comment
Assuming the Electromed Inc 's fiscal year would have ended in Jun 30 2026, Electromed Inc would have reprted above average annual Revenue increase of 12.67% year on year, of $ 72 millions.
This marks a slow-down of the companys growth trends and from the 15.57% rise in Mar 31 2026.

In the Healthcare sector 193 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 954 to 1012.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 194
Overall # 1012

Revenue TTM Y/Y Growth Statistics
High Average Low
28.9 %
10.31 %
-22.64 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 114
Sector # 312
S&P 500 # 2085




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ELMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Novocure Limited15.60%$ 15.603 millions
Ufp Technologies Inc 15.56%$ 15.558 millions
Orthopediatrics Corp15.55%$ 15.551 millions
Jazz Pharmaceuticals Plc15.55%$ 15.548 millions
Alphatec Holdings Inc 15.35%$ 15.349 millions
Penumbra Inc14.90%$ 14.904 millions
Rockwell Medical inc 14.69%$ 14.687 millions
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions


About Electromed Inc Revenue Growth Rates (ELMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Electromed Inc (CIK 1488917).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-028914
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Electromed Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.